Wealthspire Advisors LLC bought a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 11,327 shares of the company’s stock, valued at approximately $87,000. Other institutional investors and hedge funds have […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) was up 8% on Monday . The stock traded as high as $10.55 and last traded at $10.40. Approximately 868,527 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 7,476,085 shares. The stock had previously closed at $9.63. Analyst Upgrades […]
The CEO of Anagenex believes that the company's AI engine trained on billions of data points and iterative testing will blow other AI drug discovery startups out of the water.